TRE (Time-Restricted Eating)

TRE produces modest fat loss primarily by suppressing spontaneous calorie intake by approximately 200 to 350 kcal per day, not through circadian biology per se. The TREAT trial (Lowe 2020 JAMA Internal Medicine, n=116) and TREATY-FAST (Liu 2022 NEJM, n=139) both delivered negative results when calories were matched. Oldenburg 2025 Obesity, a 3-arm RCT using hyperinsulinemic-euglycemic clamp and MRI, showed TRE -1.4 kg vs CR -2.5 kg, with TRE showing lower metabolic flexibility than CR. The Cochrane 2026 review (n=1,995) rated all evidence low-certainty and concluded TRE may result in little to no difference in percent weight loss vs regular dietary advice. The realistic expectation: 3 to 8 percent body weight loss over 8 to 12 weeks per ADA 2025 Standards of Care, equivalent to continuous CR.

The original Zhang AHA 2024 abstract reported HR 1.91; the peer-reviewed full publication (Chen et al. 2025, Diabetes Metabolic Syndrome and Obesity) revised the hazard upward to 2.35 (95% CI 1.39-3.98) for 8-hour eating windows in NHANES participants. Methodological criticisms still apply: 2-day dietary recall extrapolated across 8 years of follow-up, n=414 with only 31 deaths, residual confounding for race, socioeconomic status, smoking, and BMI, and reverse causation (people in extremis often skip meals). Donald Lloyd-Jones, former AHA president, called the data not ready for prime-time consumption. The signal warrants caution but does not establish causation. Real risk likely smaller than HR 2.35 in healthy populations.

Women show meaningful sex-specific responses to TRE that men do not. Mindy Pelz advocates cyclical TRE matched to menstrual phase: longer windows during follicular phase (up to 17h fasted), zero TRE in late luteal phase from day 20 through cycle end. Stacy Sims hard-counters this for active women, citing kisspeptin sensitivity and female athlete triad risk. Peters 2025 ChronoFast (Sci Trans Med, n=31 women crossover) found neither early nor late isocaloric TRE improved insulin sensitivity or any cardiometabolic marker despite circadian clock shifts, contradicting Sutton 2018 results in men. Lean active women using windows over 14 hours risk HA and triad. Higher-stress, higher-training-load women should default to gentler 12:12 or skip TRE entirely. PCOS is one indication where TRE matched 25 percent CR for weight loss in 2026 Nature Medicine 6-month RCT (n=76) and decreased free androgen index more than CR.

Early TRE (eTRE, typically 8am to 4pm) outperforms late TRE (lTRE, noon to 8pm) for cardiometabolic markers in head-to-head comparisons, per the Chen 2026 BMJ Medicine network meta-analysis of 41 RCTs (n=2,287). eTRE achieved P-scores of 0.62 to 0.99 across body weight and fasting insulin endpoints. The mechanism: eating aligned with morning cortisol and circadian insulin sensitivity peaks, plus avoiding late-evening eating that disrupts melatonin and sleep architecture. Cienfuegos 2021 found eTRE better than lTRE for cortisol and sleep alignment. Sutton 2018 Cell Metabolism used 8am-3pm eTRE in n=8 prediabetic men with isocaloric design and found insulin sensitivity and blood pressure improvements without weight loss. The catch: eTRE has lower adherence. The 11am-7pm window has roughly 20 percent higher adherence in real-world data despite weaker metabolic outcomes.

TRE in a calorie deficit can cost lean mass: TREAT 2020 reported 65 percent lean mass loss at 12 weeks of 16:8 in a deficit, the worst single TRE finding for body composition. However, a 2025 RCT in Journal of the International Society of Sports Nutrition demonstrated that hypercaloric TRE plus resistance training plus 2.2 g/kg/d protein plus a 10 percent surplus produced muscle gain comparable to non-TRE controls, exonerating TRE in the muscle-gain context. The conditions for muscle preservation under TRE: protein at 2.2 g/kg/d minimum, resistance training 3 to 4 times weekly, eating window of 8 hours or longer (not 4-hour windows or OMAD), and avoiding large deficits during cuts. OMAD carries highest LBM risk regardless of protein due to digestive ceiling on per-meal protein utilization.

Under isocaloric conditions TRE matches but does not exceed CR. Oldenburg 2025 Obesity, the gold-standard 3-arm RCT comparing TRE vs 15 percent CR vs unrestricted using hyperinsulinemic-euglycemic clamp and MRI, found TRE -1.4 kg (p=0.53 NS) vs CR -2.5 kg (p=0.18 NS). TRE showed lower metabolic flexibility than CR. Layne Norton has been the loudest skeptic, repeatedly noting no advantage when calories and protein are equated. The practical implication: TRE works for people who find time-windowing easier than calorie counting, but offers no metabolic magic over CR alone. The 2026 Nature Medicine PCOS trial showed TRE = 25 percent CR for weight loss but TRE specifically reduced free androgen index, suggesting condition-specific advantages in hyperandrogenic populations.

Black coffee is universally accepted as fast-compatible across the practitioner community (Panda, Mattson, Fung, Pelz). Rhonda Patrick is the prominent dissent, arguing strict autophagy-targeted fasts should exclude coffee. For TRE specifically (which targets metabolic and circadian benefits, not deep autophagy), black coffee is fine. Apple cider vinegar (15-30 mL diluted), unflavored electrolytes (sodium, potassium, magnesium), and plain water are all considered fast-safe. Bulletproof coffee with butter or C8 MCT oil is the gray zone: it raises insulin minimally but does provide calories that technically break a fast for autophagy purposes; for metabolic-window TRE it is generally acceptable. The community consensus: anything under 50 calories with negligible insulin response is fast-compatible for TRE goals.

Do not do TRE if pregnant or breastfeeding (absolute contraindication), under 18 (Helmholtz Munich 2025 flagged adolescent beta cell developmental risk), with a history of eating disorders (Stice 2008 5-year prospective showed fasting was the strongest independent predictor of binge eating or bulimia onset), or in chronic high-stress states. TRE is itself a biological stressor. If baseline allostatic load is already elevated (chronic illness, burnout, overtraining, major life transitions), adding TRE compounds the stress. Drug-interaction precautions: SGLT2 inhibitors plus fasting risks euglycemic DKA; insulin and sulfonylureas require mandatory prescriber-supervised dose adjustment; levothyroxine has timing variability concerns. Lean active women using windows over 14h should monitor for menstrual irregularity, sleep disruption, or cold intolerance as early signals of HPA dysregulation.